zintick

Tenax Therapeutics TENX

Tenax Therapeutics, Inc. · Nasdaq · Pharmaceutical Preparations

$1.88+9.30%close on Oct. 28, 2026 · volume 1.6M · Yahoo Finance

Price, last 47 sessions

$1.50$1.75$2.00$2.25Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $2.32 · low $1.36 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 21, 2026ADAR1 Capital Management LLC
with Daniel Schneeberger
10% owner · indirect
Bought331,979$1.66$550,687
Oct. 20, 2026ADAR1 Capital Management LLC
with Daniel Schneeberger
10% owner · indirect
Bought254,342$1.60$405,726
Oct. 19, 2026ADAR1 Capital Management LLC
with Daniel Schneeberger
10% owner · indirect
Bought336,528$1.51$507,013
Sept. 16, 2026Declan Doogan
director
Bought53,000$1.92$101,760
Sept. 15, 2026Christopher Thomas Giordano
CEO, director
Bought4,850$1.82$8,837
Sept. 11, 2026Christopher Thomas Giordano
CEO, director
Bought6,000$1.88$11,250
Sept. 11, 2026Thomas R. Staab II
Chief Financial Officer
Bought5,675$1.94$10,981
Sept. 3, 2026ADAR1 Capital Management LLC
with Daniel Schneeberger
10% owner · indirect
Bought900,000$1.78$1.60 million
Sept. 2, 2026ADAR1 Capital Management LLC
with Daniel Schneeberger
10% owner · indirect
Bought187,704$1.80$337,586
Sept. 1, 2026ADAR1 Capital Management LLC
with Daniel Schneeberger
10% owner · indirect
Bought179,058$1.80$321,570
Aug. 31, 2026ADAR1 Capital Management LLC
with Daniel Schneeberger
10% owner · indirect
Bought403,571$1.79$722,594
Aug. 24, 2026ADAR1 Capital Management LLC
with Daniel Schneeberger
10% owner · indirect
Bought107,374$1.75$188,355

Latest 12 of 14. Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 31 →